HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor activity and toxicological properties of doxorubicin conjugated to [alpha],[beta]-poly[(2-hydroxyethyl)-L-aspartamide] administered intraperitoneally in mice.

Abstract
A polymer-drug conjugate was developed by conjugating doxorubicin (DOX) to [alpha],[beta]-poly[(2-hydroxyethyl)-L-aspartamide] (PHEA) with a succinic spacer. The suitability of PHEA-DOX in intraperitoneal chemotherapy was investigated both in vitro and in vivo. The results showed that the release rate of DOX from PHEA-DOX in S180 ascites was faster than that in mouse serum or in buffer solutions. An in-vivo antitumor study revealed that PHEA-DOX was more effective than DOX against solid S180 tumor after intraperitoneal injection at the same dose of 10 or 15 mg (DOX eq.)/kg, respectively. At a high dose of 28 mg (DOX eq.)/kg, which was lethal for free DOX to mice, PHEA-DOX could inhibit 61.5% of solid S180 tumor growth and markedly prolonged the survival time of ascetic S180-bearing mice. The toxicological effects of PHEA-DOX injected intraperitoneally in normal mice were assessed by using LD50, body weight increment, electrocardiography, blood biochemical indices, and myocardium histology, giving evidence that PHEA-DOX displayed considerably reduced systemic and cardiotoxicity compared with free DOX. All results suggest that PHEA-DOX has great potential for intraperitoneal chemotherapy because of its high therapeutic effects and few adverse side effects.
AuthorsCheng Cheng, Weihua Xue, Huajia Diao, Suhua Xia, Longsheng Zuo, Aijun He, Fengbo Gao, Zhen Huang, Jiangning Chen, Junfeng Zhang
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 21 Issue 4 Pg. 362-71 (Apr 2010) ISSN: 1473-5741 [Electronic] England
PMID20468087 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibiotics, Antineoplastic
  • Cytotoxins
  • Peptides
  • alpha,beta-poly((2-hydroxyethyl)-aspartamide)
  • Doxorubicin
Topics
  • Animals
  • Antibiotics, Antineoplastic (administration & dosage, therapeutic use, toxicity)
  • Cell Line, Tumor
  • Cytotoxins (administration & dosage, therapeutic use, toxicity)
  • Dose-Response Relationship, Drug
  • Doxorubicin (administration & dosage, analogs & derivatives, therapeutic use, toxicity)
  • Female
  • Humans
  • Injections, Intraperitoneal
  • Mice
  • Mice, Inbred ICR
  • Peptides (administration & dosage, chemistry, therapeutic use, toxicity)
  • Sarcoma 180 (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: